Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6001714 | Thrombosis Research | 2014 | 6 Pages |
Abstract
Renal function could be determined for 5,710 VTE patients. Of these 21.4% had an eGFRÂ >Â 90Â mL/min, 38.1% had an eGFR of 60-89Â mL/min, 17.3% had an eGFR of 45-59Â mL/min, 12.5% had an eGFR of 30-44Â mL/min, 7.2% had an eGFR of 15-29Â mL/min and 3.6% of the VTE patients had end-stage renal disease. Persistent severe RI was observed in 74.8% of patients with an eGFR <Â 30Â mL/min. Overall, 40.6% of the VTE patients investigated had an eGFR <Â 60Â mL/min; 10.8% had an eGFR <Â 30Â mL/min. Almost three quarters of RI-VTE patients suffered from persistent severe RI. These results suggest that more than one in ten VTE patients is exposed to a high risk of accumulating anticoagulants; most of these RI patients also face an increased risk of mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Björn Böttger, Martin Wehling, Rupert M. Bauersachs, Steffen Amann, Andreas Schuchert, Christian Reinhold, Philipp Kümpers, Thomas Wilke,